PEGASI MED

We are committed to making medical information accessible, clear and useful for clinicians and patients in the developing world, while tracking epidemic and endemic diseases, and creating actionable insights that help strengthen our Healthcare systems.

We use our 4-step method to structure, process, aggregate and analyze Healthcare information. In the first two steps, we use PEGASI MED, our EHR platform for the developing world. PEGASI MED covers over 30 medical specialties, is accessible using any smart device, is built using international standards for clinical data management, complies fully with HIPAA / HITECH, and uses Machine Learning to support clinical decision making.

In a global scale, PEGASI MED's datalakes form PEGASI BI, aggregating and analyzing clinical information through advanced dashboards and Artificial Intelligence models, in order to create early epidemic warnings, locate endemic diseases, improve medical research through the review of prospective and retrospective records, and procure comprehensive patient attention.

Crisis management depends on having reliable sources of information readily available, both to detect trends and to act upon them. In Healthcare, information gathering is delegated to practitioners and support personnel dealing with everyday ailments. 

More than 70% of Healthcare information gathered in the developing world remains unstructured, on paper. Months go by until we have a clear snapshot of a city, state or country's status.

In everyday cases, accessibility, reliability and security of Healthcare information are factors that heavily contribute to adverse events, which affect 1 out of 100 hospitalized patients in Latin America. Yet, the COVID-19 crisis has shown us that lack of real-time access to this information has made our regions more vulnerable, as strategies cannot be devised based on accurate information.

That is why we are focusing on creating reliable and secure access to clinical information, in order to help clinicians in their everyday tasks, to support their decision-making with special algorhythms and to, finally, allow real-time Population Health monitoring.

After 20 years of experience in the Latin American Healthcare IT market, we created a 4-step method to structure, process, aggregate and analyze Healthcare information in order to track epidemic and endemic diseases. 

The first two steps we handle through PEGASI MED, our affordable, web based EHR platform. PEGASI MED works on any smart device and is available both offline and online. It offers teleconsultation capabilities through international Healthcare data structures, while being fully compliant with HIPAA and GDPR to ensure patients the security of their information and allowing Business Intelligence generation for local research.

Within the same platform, PEGASI MED users find all the tools needed to handle clinical information: 

• patients' demographic data handling, including personal records, appointments, ingress, egress and transfers;
• electronic medical records for over 30 different medical specialties (intensive care, emergency, pediatrics, gynecology, etc.);
• clinical and pathological laboratory management, which allows test results to be available to patients online;
• imagenology laboratory management through a RIS / PACS suite; and
• personalized statistics creation suite.

Data structured and processed by PEGASI MED is aggregated, anonymized and analyzed as Big Data in PEGASI BI, thus fueling our clinical decision support models and our endemic and epidemic disease tracking dashboards.

Our solution serves patients first, making healthcare information accessible, clear and secure for them. They become protagonists of their healing process and diminish their chances of being affected by an adverse event.

Our solution also serves physicians, by reducing manual work overload, automating data search and creating ideal circumstances for research.

Finally, our solution serves population as a whole. Patient aggregate data is used to track dangerous diseases and clusters of infection that could endanger us all.

One of the key aspects in our difficulty handling epidemics-turned-pandemics, such as COVID-19, is our inability to feed our analysis with real-time information that allows devising consensual strategies. If clustered anamnesis, vital signs, mechanical ventilation, paraclinical exams and intervention reports were fed via teleconsultation and readily available for situation monitoring, the outlook of epidemics would be completely different. And that's what we aim to do with PEGASI in the developing world: to provide a platform that is easily adopted by physicians, that anonymizes patient information for tracking diseases and that support clinical decision making through the use of Artificial Intelligence.

We have 256 physicians and 117,602 patients using our platform presently, over 6 different countries: Dominican Republic, Venezuela, Peru, Chile, Colombia & Ecuador. Of those, 152 physicians operate in consultation offices and 104 are using our centralized EHR in clinics or hospitals from Dominican Republic, Peru and Chile. Patient population characteristics vary between those countries. We've also used our platform to track COVID-19 cases on intensive care settings in Chile, and to record genomic testing results for breast & lung cancer in Peru, through an alliance with Roche Laboratories and 3 public institutions in the country.

PEGASI promotes regional reach with PEGASI MED, focusing on concepts such as access via teleconsultation to a central medical record for regional patients and anonymization of information for Big Data purposes. PEGASI's team members also took the experience they had in the Banking and Fintech industry, and are the first to use data protection patterns reserved for financial information in order to insure information integrity.

PEGASI MED is the first Healthcare Information System to offer synchronized local and Cloud facilities to overcome Internet shortages common in the developing world, while offering specialized forms for 30+ clinical specialties in a centralized format. In addition, all the information loaded in PEGASI MED can be analyzed as Big Data, for the production of clinical-administrative reports.

Finally, growth space for new AI models that support clinical decision making is always available, due to the unique way PEGASI MED's data is treated.

We have 256 physicians and 117,602 patients using our platform presently, over 6 different countries: Dominican Republic, Venezuela, Peru, Chile, Colombia & Ecuador.  Of those, 152 physicians operate in consultation offices and 104 are using our centralized EHR in clinics or hospitals from Dominican Republic, Peru and Chile. Patient population characteristics vary between those countries. We've also used our platform to track COVID-19 cases on intensive care settings in Chile, and to record genomic testing results for breast & lung cancer in Peru, through an alliance with Roche Laboratories and 3 public institutions in the country. 

We have a dashboard that continually monitors several impact KPIs:

• Number of patients in the platform;
• Number of physicians using the platform;
• Number of epidemic diseases diagnosed;
• Number and types of endemic diseases identified;
• Number of drug interaction warnings issued;
• Number of paper print-outs prevented by sending documents in digital format;
• Number and types of diagnosis registered per region.

We are 21 full-time Latin American Health transformers implementing Smart Healthcare information management for the region: 4 officials, 11 developers, 3 marketing specialists and 3 sales specialists.

Our team has a over 20 years of joint commercial, technical and implementation experience in the Healthcare IT of Latin America, developing solutions that take top technology and shape it in the way our stakeholders work. We also have a very strong technical background, coming from the Banking IT business -accustomed to applications used by millions every single day- and also from the clinical direction, digital transformation and international consultancy areas. Finally, we have a group of mentors, advisors and coaches that lead us through the latest technology in Healthtech, but also through tough commercial and design decisions.

We are on the continuous lookout to hire talent without discrimination. Our managers are female and our most recent hires are female as well, while we aim for the 50% of the team to be female by the end of 2021. In terms of ethnicity, socioeconomic status, gender identification and sexual preference, our team has extremely diverse backgrounds, and this doesn't factor in our evaluation process while hiring. Finally, we promote inside of the organization without any restrictions based on age, gender, ethnicity, sexual preference or socioeconomic status. We only value talent, commitment and responsibility.

Having a community of incredible individuals that could help us think about, review and broadcast the ideas we have for tackling the difficult situation of healthcare information handling in the developing world is paramount to us. 

Our solution is not a solution designed for profit, it's a dream that we share in PEGASI ever since we started in this line of work: making Healthcare affordable and efficient for everyone, and using clinical information as a regional development tool. For this, we think Solve is a great platform to help us move forward with that dream.

We have been growing commercially in the past few months and in that sense we have a profitable operation that is highly scalable. However, what Agora Partnerships instilled in us in our previous acceleration was a desire for purpose and a clear route to accomplish it: we trust we can achieve our objective of turning developing Healthcare information into a tool for regional development, and we feel Solve has the key to unlock our full changemaking potential. We are seeking 3 specific resources: mentoring, especially regarding Artificial Intelligence -technologies in which we have experience but we also identify a huge opportunity for learning-; access to a network of key actors that can make the change we want to make long-lasting, and capital to expand our operation in a conscious, impact-driven way.

We would like to partner with multilateral organizations that manage Healthcare in the world, such as Red Cross, PAHO and WHO, to whom we can provide services for handling healthcare information. This would ultimately help us grow our Big Data repository more quickly, which would in turn provide more accurate information of endemic and epidemic diseases in the region.

Using PEGASI MED and the Big Data that Roche, the government of Peru, regional governments of Chile and the government of Ecuador generate, we monitor the incidence of human papillomavirus or HPV, which causes cervical cancer in women. We will cover a population of over 14,000 women in the first iteration of the pilot, to be completed by december 2021.

In this model we've also analyzed the results of over 200 women with breast cancer suspicion by supporting Roche Laboratories, accelerating an accurate diagnosis and increasing the speed of treatment by over a month.

We've discovered an amazing opportunity of delivering better Healthcare to women in the developing world by closing an information loop between patients, physicians and service providers. In order to make this approach work, we need connections and legal assistance to scale our operations throughout Latin America at first, then the rest of the developing world. This would be the purpose of this prize.